Skip to main content
. 2026 Oct 13;18(10):1295. doi: 10.3390/pharmaceutics18101295
ARG1 Arginase 1
BSA Bovine serum albumin
CAF Cancer-associated fibroblast
CCL2 C-C motif chemokine ligand 2
CCR2 C-C chemokine receptor 2
CRC Colorectal cancer
CSF1 Colony-stimulating factor 1
CSF1R Colony-stimulating factor 1 receptor
Cur Curcumin
DC Dendritic cell
DOX Doxorubicin
GBM Glioblastoma
GSDME Gasdermin E
HCC Hepatocellular carcinoma
HIF-1α Hypoxia-inducible factor 1 alpha
ICD Immunogenic cell death
IFN-γ Interferon gamma
iNOS Inducible nitric oxide synthase
LC-MS Liquid chromatography–mass spectrometry
LUAD Lung adenocarcinoma
MAPK Mitogen-activated protein kinase
MDSC Myeloid-derived suppressor cell
miR MicroRNA
NF-κB Nuclear factor kappa B
NK Natural killer
NP Nanoparticle
PD Pharmacodynamics
PDA Polydopamine
PK/PD Pharmacokinetics/pharmacodynamics
PLGA Poly(lactic-co-glycolic acid)
ROS Reactive oxygen species
siRNA Small interfering RNA
STAT Signal transducer and activator of transcription
TAM Tumor-associated macrophage
TCR T-cell receptor
TGF-β Transforming growth factor beta
TIDE Tumor Immune Dysfunction and Exclusion
TME Tumor microenvironment
TNBC Triple-negative breast cancer
TNF-α Tumor necrosis factor alpha
VEGF Vascular endothelial growth factor